🇺🇸

US SEC Filing Intelligence

· daily

US Executive Compensation Proxy SEC Filings — June 05, 2026

This intelligence stream analyzes 6 pre-analyzed SEC filings (DEF 14A/DEFM14A) from the period ending June 5, 2026, focusing on executive compensation, governance, and shareholder actions. The filings reveal a pronounced theme of corporate restructuring and capital structure management, with Movano Inc. completing a merger that resulted in a pro forma net loss of $68.4M for FY2025, while Curis Inc. and Artelo Biosciences are pursuing reverse stock splits to maintain listing compliance. Insider trading activity is notably absent across all filings, suggesting a lack of direct management conviction signals. Capital allocation trends are mixed, with Movano showing significant stock issuance for M&A, while Artelo proposes a tripling of authorized shares. The forward-looking landscape is dominated by upcoming shareholder meetings in late June and July 2026, creating a catalyst calendar for governance decisions. Period-over-period comparisons are limited, but Movano's pro forma data reveals a deteriorating financial trajectory with a net loss per share of $(33.53) for FY2025. The most critical development is the high materiality of Movano's merger (9/10), which presents both risk and opportunity given its preliminary financials and VIE structure. Overall, the filings suggest a market environment where small-cap and SPAC entities are aggressively restructuring, with governance actions (reverse splits, share increases) serving as key near-term catalysts.

6 high priority 6 total filings
· daily

US IPO Pipeline SEC S-1 Filings — June 05, 2026

The IPO pipeline is active with five new S-1 filings on June 5, 2026, spanning digital assets, mining, quantum computing, and retail, alongside two follow-on filings for debt exchange and ETF creation. A key theme is the prevalence of 'controlled company' structures post-IPO, with ITG, Sinda Ltd., and SharonAI all featuring dual-class shares or majority control by existing owners, limiting minority shareholder influence. Financially, Banzai International shows a mixed picture with 18.4% revenue growth but a net loss that more than doubled to $12.7M in Q1 2026, highlighting the cash-burn risks typical of pre-profit IPOs. The Grayscale Canton ETF and SharonAI filings underscore the continued institutional push into digital assets despite extreme volatility. A major red flag is Zapata Quantum's S-1, filed despite ceasing operations in 2024, with a low OTC stock price and no clear path to uplisting, suggesting a distressed or speculative offering. Overall, the pipeline is diverse but carries significant execution and governance risks, with only DICK'S Sporting Goods offering a low-risk, neutral debt exchange.

7 high priority 7 total filings
· daily

Global High-Priority Regulatory Events — June 05, 2026

The June 5, 2026, filing stream reveals a market bifurcated between aggressive capital deployment (buybacks, M&A, debt raises) and escalating financial distress, particularly in Indian small-caps and US cash-burning tech. A clear theme is the use of complex financial engineering to manage liabilities, with Gossamer Bio exchanging high-coupon debt for equity and Ferrellgas completing a major refinancing, while several companies like Shoe Carnival and Clean Energy Technologies show worsening cash positions. Insider activity is sparse but notable, with a significant pledge by a Paisalo Digital promoter and a complete change of control at P.H. Capital Ltd. via an open offer. Forward-looking statements are dominated by M&A catalysts, including a binding MOU from iQSTEL that could 4x net income and a non-binding LOI from FACT II Acquisition Corp. The most critical developments are the insolvency petition against TV Vision Ltd. and the continued delays in the Vikas WSP CIRP, signaling heightened credit risk in the Indian market. Overall, the data suggests investors should favor companies with strong organic growth and clean balance sheets (e.g., Victoria's Secret, Guidewire) while avoiding those with deteriorating liquidity and operational losses.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — June 05, 2026

This intelligence stream reveals a highly polarized earnings season across the 32 filings, characterized by a clear divergence between high-growth tech/data infrastructure companies and struggling retail/discretionary names. A dominant theme is 'revenue growth at the expense of margins,' with 7 out of 12 tech-centric firms (NetApp, Pure Storage, Rubrik, ServiceTitan, etc.) reporting double-digit revenue growth (avg. +14.7% YoY) but simultaneously facing rising operating expenses, particularly in R&D, sales & marketing, and stock-based compensation. On the consumer side, Abercrombie & Fitch, Shoe Carnival, and Petco reported earnings declines or losses despite flat-to-slight revenue growth, as costs outpaced sales. A critical period-over-period trend is the surge in non-cash charges (e.g., litigation reserves at Cooper Companies, warrant liabilities at Planet Labs) that are distorting the quality of reported earnings. Insider activity was notable only in specific cases, but capital allocation patterns show a clear bifurcation: cash-rich tech firms (DocuSign, Veeva, Guidewire) are aggressively buying back stock (over $1B in aggregate), while retailers and materials companies are conserving cash or reducing debt. The most critical development is the widening cash burn at multiple micro-cap and shell entities (CETY, MYCB, WORLDS), signaling imminent liquidity crises, contrasted with a robust, cash-flow-positive turnaround at Best Buy and a strong earnings beat at PVH Corp. The market should watch for a potential correction in high-growth tech names as the 'cash flow vs. accounting profit' gap widens.

32 high priority 32 total filings
· daily

US SEC Trading Suspension Halt Orders — June 05, 2026

On June 5, 2026, three US-listed companies disclosed Nasdaq non-compliance notices, signaling a concentrated wave of regulatory risk in the small-cap and micro-cap space. The filings reveal a common theme of deteriorating market valuation and liquidity, with two companies (Arrive AI and Research Frontiers) failing the minimum $1.00 bid price rule and one (Driven Brands) failing timely filing requirements for the second consecutive quarter. Period-over-period data is limited as these are event-driven 8-Ks, but the recurrence of Driven Brands' filing delays (previously resolved May 19, 2026) indicates systemic internal control weaknesses. Research Frontiers faces a dual deficiency (bid price and market value of listed securities) and has explicitly ruled out a reverse stock split, increasing delisting risk. No insider trading activity or capital allocation changes were reported, suggesting management is in a holding pattern. The aggregate market implication is heightened delisting risk for three distinct companies, each with 180-day compliance windows ending November 30, 2026, creating a catalyst calendar for investors monitoring turnaround or exit strategies.

3 high priority 3 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 05, 2026

This batch of 48 SEC filings reveals a pronounced bifurcation in corporate health, with a cluster of companies in acute distress—evidenced by forbearance agreements, Nasdaq deficiency notices, and distressed debt exchanges—while others execute strategic refinancings and capital raises. The most critical themes are a wave of liquidity crises among small-cap industrials and tech firms, aggressive debt refinancing at higher costs signaling credit stress, and a surge in at-the-market (ATM) equity offerings that dilute existing shareholders. Period-over-period data, where available, shows revenue declines and cash burn rates that are unsustainable, with several companies having less than six months of runway. Conversely, a few companies like Brown & Brown and Synchrony Financial are successfully accessing capital markets on favorable terms, indicating a healthy credit environment for investment-grade entities. The overall picture is one of increasing divergence, where well-capitalized firms are strengthening their balance sheets while weaker players face existential threats, creating both high-risk and high-opportunity scenarios for investors.

48 high priority 48 total filings
· daily

US Executive Officer Management Changes SEC — June 05, 2026

This digest covers 50 enriched regulatory filings from June 5, 2026, focusing on USA Executive & Director changes. A dominant theme is the wave of director and officer resignations, with lesser immediate materiality but potential cumulative governance impact, including the coordinated resignation of Jordan Krugman from five Invesco trusts. Several high-conviction shifts were identified: the sudden, immediate resignations at Aditxt (General Counsel and Audit Chair) and the departure of Purple Innovation's COO, creating governance gaps and operational risk. Conversely, strong positive signals came from shareholder meetings: Assembly Biosciences and Lucid Group saw overwhelming support for executive compensation, while GoDaddy's compensation plan passed with 92% approval. The most critical governance flashpoint is at NovoCure, whose 2024 Omnibus Incentive Plan passed by a razor-thin 0.6% margin, signaling deep shareholder discontent. A concerning pattern of elevated director dissent appeared at Claros Mortgage Trust (23% withheld for one director) and Red Violet (55% withheld), indicating activist risk. The period's data reveals minimal high-materiality insider buying, but forward-looking data points to upcoming catalyst events, notably DBV Technologies' PSU plan tied to FDA approval. Overall, the period is characterized by orderly transitions punctuated by a few acute risks, with specific AGM votes providing actionable signals on shareholder sentiment. On a period-over-period basis, no broad financial trends were discernible from these filings as they primarily disclose corporate events rather than operational metrics. However, capital allocation patterns show a continued reliance on equity-based compensation to align management, with several companies (Carlyle, Claros, NovoCure) facing notable shareholder dissent on these plans.

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — June 05, 2026

This batch of 50 SEC filings reveals a significant wave of board and C-suite changes across US-listed companies, with notable patterns in shareholder dissent and executive departures. The most critical development is the concentrated resignation of Jordan Krugman from five Invesco-sponsored trusts, signaling a potential broader governance shift within the sponsor's management. Several annual meetings show elevated shareholder opposition, with NovoCure's equity plan passing by a razor-thin 0.6% margin and Claros Mortgage Trust receiving 33.6% 'against' votes on say-on-pay, indicating growing investor activism. The data reveals a trend of orderly CFO transitions, with companies like CaliberCos and Longeveron promoting internal candidates, while Aditxt's immediate loss of its General Counsel and Audit Committee Chair creates a governance vacuum. Key insider activity includes DBV Technologies granting CEO Daniel Tassé 4.06 million PSUs tied to FDA approval milestones, and Trio Petroleum awarding CEO Robin Ross a 50% salary increase plus 1.5 million shares. The period-over-period comparisons are limited in these board-focused filings, but the forward-looking data provides a clear catalyst calendar centered on August 2026 effective dates and regulatory milestones.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — June 05, 2026

The US M&A landscape is bifurcated between high-conviction de-SPAC mergers and deeply conflicted shareholder exits. While Howard Hughes Holdings closed a transformative $2.1B acquisition of Vantage Group and Legato Merger Corp. III secured overwhelming shareholder approval for its Einride merger, Mountain Lake Acquisition Corp. saw a massive 99.3% shareholder redemption rate ($243.2M cashed out), signaling extreme distrust in SPAC economics. VSee Health's related-party divestiture to its own CEO for stock buyback raises governance red flags, while I-ON Digital's gold claims acquisition with Real Asset Acquisition Corp. collaboration shows innovative cross-entity deal structuring. The IPO of AmperCap Acquisition Co. adds fresh SPAC supply, but Ribbon Acquisition Corp.'s delisting risk for unpaid $75K fees highlights operational fragility. Period-over-period comparisons are limited due to the event-driven nature of these filings, but pro forma data reveals stark revenue impacts: VSee would lose 50% of revenues post-divestiture. Insider activity is notably absent across most filings, though Mountain Lake's sponsor distribution of 2.78M shares ahead of the vote suggests pre-emptive positioning.

10 high priority 10 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 05, 2026

Overnight filings reveal a bifurcated market with aggressive capital deployment (M&A, buybacks, debt raises) contrasting with operational headwinds. The most critical development is Berkshire Hathaway's proposed acquisition of Taylor Morrison Home Corp (TMHC), a high-conviction bet on US housing. While several companies like Planet Labs (+42% YoY revenue) and Victoria's Secret (+15% YoY sales) show strong top-line growth, margin pressures and widening losses are common themes, with Shoe Carnival swinging to a net loss and G-III Apparel seeing an 8% sales decline. A significant capital allocation trend is visible: Guidewire repurchased $392M in stock, News Corp authorized a $1B buyback, and FTI Consulting added $370M to its repurchase program, signaling management confidence. However, this is offset by aggressive debt financing from Hut 8 ($4.25B notes), Northwest Natural ($195M total), and Gossamer Bio's debt exchange (90.5% participation), indicating a search for liquidity. A notable sector theme is the convergence of AI and physical infrastructure, seen in Brand Engagement Network's investment in fleet AI and Hut 8's massive data center debt raise.

22 high priority 28 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — June 04, 2026

The two federal contracts analyzed total $2.73 billion, entirely civilian (0% defense-related), with a dominant $2.59 billion award from the Department of Homeland Security (DHS) to FISHER SAND & GRAVEL CO. This single contract accounts for 95% of aggregate value and drives a bullish signal for infrastructure and construction firms serving civilian agencies. The second award, a $139 million modification to NW CONSTRUCTION, INC from the Department of the Interior, is neutral and smaller. The highest-conviction signal is the DHS award's sheer size and sole-source nature, suggesting urgent infrastructure needs. Key risks include lack of pricing and competition details for both contracts, which could hide execution or protest vulnerabilities.

2 total filings
· daily

DOE Energy & National Labs Contracts — June 04, 2026

This digest covers a single, large civilian contract from the Department of Energy (DOE) to SURATECH LLC valued at $113.3M, representing 100% of the period's total obligation. The contract is a cost-plus-award-fee award for managing the Thomas Jefferson National Accelerator Facility (TJNAF), a mission-critical GOCO R&D site. With zero defense-related awards and a neutral signal strength of 4/10, the investment implications are limited as the recipient is a private nonprofit entity. The key risk is the lack of direct public market exposure, though the contract underscores stable DOE funding for nuclear physics infrastructure, which may benefit subcontractors or adjacent publicly traded firms.

1 total filings
· daily

DHS Homeland Security Contracts — June 04, 2026

During the single-day period of June 4, 2026, the Department of Homeland Security awarded a sole $2.59 billion contract to Fisher Sand & Gravel Co, representing the entirety of the stream's aggregate obligation. This is a civilian (non-DoD) award with a bullish signal strength of 7/10 and high materiality of 8/10, but critical data gaps on pricing, competition, and revenue exposure limit full risk assessment. The dominant theme is a massive, single-source infrastructure contract under DHS, likely for border or facility construction, which creates extreme contractor concentration risk. Key watch items include the lack of competitive moat details and the potential for protest or execution delays given the award size relative to Fisher Sand & Gravel's unknown annual revenue.

1 total filings
· daily

New Federal Contractors — June 04, 2026

The four contracts analyzed total $3.08 billion in obligations, all from civilian agencies, with zero defense-related awards. The dominant theme is a massive, single $2.59 billion Department of Homeland Security award to FISHER SAND & GRAVEL CO, which accounts for 84% of total value and is the only bullish signal (strength 7/10). However, this award lacks pricing, competition, and revenue detail, creating significant uncertainty. Leidos, Inc. secured a $234.9 million firm-fixed-price IT support contract from CMS, a neutral signal reinforcing its competitive position in civilian IT services. The remaining two awards—NW CONSTRUCTION, INC ($139.3M, Interior) and SURATECH LLC ($113.3M, DOE)—are neutral, with the latter being a long-term management contract for a government-owned facility. Key risk: the FISHER SAND & GRAVEL award’s opacity and lack of public company exposure limit direct investment actionability.

4 total filings
· daily

Significant Contract Modifications ($10M+) — June 04, 2026

The four contract modifications analyzed, totaling $3.08 billion, are entirely civilian in nature, with zero defense-related awards. The dominant signal is a massive $2.59 billion sole-source award to FISHER SAND & GRAVEL CO from the Department of Homeland Security, representing 84% of total obligation value and carrying a bullish 7/10 signal strength. However, the lack of pricing, competition, or revenue data for this award introduces significant uncertainty. The other three contracts—Leidos, Inc. ($234.9M), NW CONSTRUCTION, INC ($139.3M), and SURATECH LLC ($113.3M)—are neutral signals with lower materiality. Key risk: the FISHER SAND & GRAVEL award's opaque terms and the fact that it is a civilian contract (DHS) rather than defense, making it more vulnerable to budget shifts or continuing resolution (CR) impacts. Investors should watch for outlay data on the FISHER contract and Leidos' CMS renewal prospects.

4 total filings
· daily

Contract Deobligations Alert — June 04, 2026

The digest covers $3.08 billion in total obligations across four civilian agency contracts, with zero defense-related awards. The dominant signal is the $2.59 billion sole-source award to FISHER SAND & GRAVEL CO from the Department of Homeland Security, which accounts for 84% of total value and carries a high materiality bullish signal, though the lack of public disclosure on pricing terms and competitive moat introduces execution risk. Leidos, Inc. secured a $234.9 million firm-fixed-price IT contract from HHS/CMS, reinforcing its competitive position in healthcare IT services but with near-completion status and medium pricing risk. A $139.3 million Interior modification for NW CONSTRUCTION, INC and a $115.7 million DOE GOCO facility award to private nonprofit SURATECH LLC are neutral signals with limited direct investment impact. Key watch items include the opaque terms and protest vulnerability of the FISHER SAND & GRAVEL contract and Leidos’ upcoming CMS renewal cycle.

4 total filings
· daily

Contract Option Exercises — June 04, 2026

The digest covers $3.08B in total obligations across four civilian-agency contract actions on June 4, 2026, with zero defense-related awards. The dominant signal is a massive $2.59B Department of Homeland Security award to FISHER SAND & GRAVEL CO, which accounts for 84% of total value and carries a bullish 7/10 signal strength, though the company is private and lacks public revenue data. A $234.9M Leidos IT services contract with CMS shows stable civilian IT demand but is near completion. The aggregate is heavily skewed by one outsized award, creating concentration risk, and the absence of defense contracts limits sector-wide implications for defense-focused portfolios. Key watch items include Leidos' CMS contract renewal and DOE budget allocations for SURATECH LLC's TJNAF facility.

4 total filings
· daily

Federal IT & Cybersecurity Contracts — June 04, 2026

This digest covers a single $234.9M firm-fixed-price IT services delivery order awarded to Leidos, Inc. by the Department of Health and Human Services (CMS), with zero defense-related contracts in the period. The dominant theme is civilian healthcare IT modernization, with Leidos reinforcing its competitive position in a full-and-open competition. The highest-conviction signal is neutral: the contract is near completion (2018-2023) with only $112M outlayed, implying potential under-execution or delayed obligations. A key risk is the fixed-price pricing structure transferring cost risk to Leidos, though IT services margins are typically manageable.

1 total filings
· daily

All HHS Contracts — June 04, 2026

This digest covers a single $234.9M firm-fixed-price IT services delivery order awarded to Leidos, Inc. by the Department of Health and Human Services (HHS) via the Centers for Medicare & Medicaid Services (CMS). The contract is entirely civilian, with no defense-related exposure, and represents a stable, near-completion award from 2018 to 2023. The highest-conviction signal is neutral: Leidos' competitive win in a full-and-open competition reinforces its IT services moat, but the contract is mature with only $112M outlayed, implying limited near-term revenue upside. A key risk is the absence of follow-on awards or renewal signals, which could create a revenue gap for Leidos' HHS/CMS segment.

1 total filings
· daily

All DOE Contracts — June 04, 2026

The sole contract analyzed for June 4, 2026, is a $113.3M Department of Energy (DOE) award to SURATECH LLC for managing the Thomas Jefferson National Accelerator Facility (TJNAF). This is a purely civilian, non-defense contract with a neutral signal strength (4/10) and low materiality (2/10) for public markets, as SURATECH is a private nonprofit. The cost-plus-award-fee structure reduces profit risk but limits upside, and the 5-year term signals stable, mission-critical DOE funding for nuclear physics R&D. The key risk is the lack of direct public equity exposure, though subcontractors or adjacent firms may benefit. No bullish or bearish signals were identified, making this digest a baseline observation of DOE facility management contracting.

1 total filings